Clopidogrel: Interactions with the P2Y12Receptor and Clinical Relevance
- 1 December 2003
- journal article
- review article
- Published by Taylor & Francis in Hematology
- Vol. 8 (6) , 359-365
- https://doi.org/10.1080/10245330310001621260
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Coordinated Signaling through Both G12/13 and Gi Pathways Is Sufficient to Activate GPIIb/IIIa in Human PlateletsPublished by Elsevier ,2002
- Signaling through Gi Family Members in PlateletsJournal of Biological Chemistry, 2002
- Impaired activation of murine platelets lacking Gαi2Journal of Clinical Investigation, 2001
- P2Y12, a New Platelet ADP Receptor, Target of ClopidogrelBiochemical and Biophysical Research Communications, 2001
- ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999Journal of Biological Chemistry, 2001
- Novel Platelet InhibitorsAnnual Review of Medicine, 2001
- Antiplatelet action of R‐99224, an active metabolite of a novel thienopyridine‐type Gi‐linked P2T antagonist, CS‐747British Journal of Pharmacology, 2001
- Deaggregation is an integral component of the response of platelets to ADP in vitro : kinetic studies of literature and original dataPlatelets, 2001
- Role of the Extracellular Loops of G Protein-Coupled Receptors in Ligand Recognition: A Molecular Modeling Study of the Human P2Y1ReceptorBiochemistry, 1999
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996